
Synaptogenix, Inc.
@synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. $SNPX
ID: 1408065757741682698
http://www.synaptogen.com 24-06-2021 14:14:03
168 Tweet
131 Followers
23 Following


Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in #SpinalCordInjury. Read the press release here: prn.to/46iaYrp $SNPX LSU Health Sciences #PreclinicalResearch #Biopharmaceutical #Neuroscience


ICYMI: New collab to probe potential of fatty acid analogs in #Alzheimer's. Our collab with LSU Health Sciences will focus on #preclinical testing of our polyunsaturated fatty acid analogs for treating spinal cord injuries. More via The Pharma Letter: bit.ly/3LTul0r $SNPX



Synaptogenix is pleased to announce the appointment of #crypto and AI expert to lead digital asset treasury strategy focused exclusively on top-valued #AI token. Read the press release: bit.ly/4dXIFT1 $SNPX $TAO #Bittensor James Altucher



Synaptogenix is targeting $100M in $TAO tokens and will be the only pure play focused exclusively on this leading #AI / #crypto token! BeInCrypto features our yield-generating digital asset strategy led by James Altucher. bit.ly/3FUV6SQ $SNPX #Bittensor #TAO











